Research suggests that broccoli sprouts and their key bioactive compound sulforaphane may offer meaningful anti-inflammatory benefits, particularly in the context of gut inflammation and viral respiratory illness. Studies indicate that diets incorporating broccoli sprouts reduced markers of intestinal inflammation, preserved healthy gut bacterial diversity, and mitigated symptoms in animal models of both Crohn's disease-like colitis and chemically induced ulcerative colitis, with younger animals appearing to benefit more than older ones. Additional preclinical work found that sulforaphane reduced coronavirus replication, limited lung damage, and showed synergistic effects with an established antiviral drug in cell and mouse experiments. It is important to note that all four studies reviewed here were conducted in animal or cell models, meaning their findings cannot be directly applied to humans, and clinical trials would be necessary before drawing firm conclusions about efficacy in people.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Early life exposure to broccoli sprouts confers stronger protection against e... | Other | 2023 | Supports | 100 |
| Steamed broccoli sprouts alleviate DSS-induced inflammation and retain gut mi... | Other | 2023 | Supports | 85 |
| Early life exposure to broccoli sprouts confers stronger protection against e... | Other | 2023 | Supports | 80 |
| Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemi... | Other | 2021 | Supports | 75 |